KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Amortization of Deferred Charges (2016 - 2023)

Pacific Biosciences Of California has reported Amortization of Deferred Charges over the past 11 years, most recently at $155000.0 for Q2 2023.

  • For Q2 2023, Amortization of Deferred Charges rose 0.65% year-over-year to $155000.0; the TTM value through Jun 2023 reached $632000.0, up 1.44%, while the annual FY2022 figure was $640000.0, 18.74% up from the prior year.
  • Amortization of Deferred Charges for Q2 2023 was $155000.0 at Pacific Biosciences Of California, down from $156000.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $1.3 million in Q2 2020 and troughed at -$1.3 million in Q3 2020.
  • A 5-year average of $166875.0 and a median of $157000.0 in 2021 define the central range for Amortization of Deferred Charges.
  • On a YoY basis, Amortization of Deferred Charges climbed as much as 305.62% in 2019 and fell as far as 369.82% in 2019.
  • Year by year, Amortization of Deferred Charges stood at -$742000.0 in 2019, then tumbled by 70.22% to -$1.3 million in 2020, then soared by 112.51% to $158000.0 in 2021, then increased by 1.27% to $160000.0 in 2022, then fell by 3.12% to $155000.0 in 2023.
  • Business Quant data shows Amortization of Deferred Charges for PACB at $155000.0 in Q2 2023, $156000.0 in Q1 2023, and $160000.0 in Q4 2022.